Amilar (dequalinium chloride) lozenges №8

active ingredients: dequalinium chloride, dibucaine hydrochloride;

1 tablet contains dequalinium chloride 0.25 mg, dibucaine hydrochloride 0.03 mg

excipients : sorbitol (E 420), colloidal silicon dioxide, talc, magnesium stearate.

Lozenges.

Basic physical and chemical properties : tablets of white or almost white color, flat-cylindrical shape with a chamfer.

Drugs used in diseases of the throat. ATX code R02A.

As a bactericidal and fungistatic agent, dequalinium chloride affects microorganisms that cause mixed infections of the mouth and throat. The spectrum of action of this topical chemotherapeutic agent is broad and includes most gram-positive and gram-negative bacteria, as well as fungi, spirochetes, and pathogens that cause mixed infections of the mouth and throat. The accumulation of dibucaine hydrochloride in the body relieves the pain symptom that accompanies infections of the mouth and throat.

Microorganisms resistant to the action of dequalinium chloride are unknown.

Does not cause caries.

Local treatment of acute inflammatory diseases of the mouth and throat: gingivitis, ulcerative and aphthous stomatitis, tonsillitis, laryngitis and pharyngitis. Amilar IC is also recommended for use in the presence of bad breath.

Amilar IC can be used in the case of a mixed infection of the mouth and throat (on the recommendation of a doctor) as an auxiliary drug in the treatment of catarrhal angina, lacunar angina and Plaut-Vincent’s angina; in case of candidiasis of the oral cavity and pharynx.

It is recommended in the postoperative period after tonsillectomy and tooth extraction.

Hypersensitivity to any of the substances that make up the drug. Allergy to quaternary ammonium compounds (eg benzalkonium chloride).